ABVC BioPharma, Inc. (ABVC) stock

ABVCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ECOC

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 4/30

$0.96−0.03 (-3.03%)

Close on Nov 12, 2026Market cap $25.59MP/E –Yield –

ABVC BioPharma EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

ABVC BioPharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Parsed from the XBRL in ABVC BioPharma's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-10 reverse split on Jul 25, 2023
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing